Literature DB >> 23525963

Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5.

Wei Wang1, Xiaoning Cao, Xiaolei Zhu, Yongliang Gu.   

Abstract

Molecular docking, molecular dynamics (MD) simulations, and binding free energy analysis were performed to reveal differences in the binding affinities between five 2-aminothiazole inhibitors and CDK5. The hydrogen bonding and hydrophobic interactions between inhibitors and adjacent residues are analyzed and discussed. The rank of calculated binding free energies using the MM-PBSA method is consistent with experimental result. The results illustrate that hydrogen bonds with Cys83 favor inhibitor binding. The van der Waals interactions, especially the important contact with Ile10, dominate in the binding free energy and play a crucial role in distinguishing the different bioactivity of the five inhibitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23525963     DOI: 10.1007/s00894-013-1815-y

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  51 in total

1.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

Review 2.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

3.  Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.

Authors:  Georg Feldmann; Anjali Mishra; Seung-Mo Hong; Savita Bisht; Christopher J Strock; Douglas W Ball; Michael Goggins; Anirban Maitra; Barry D Nelkin
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

4.  Callosal axon guidance defects in p35(-/-) mice.

Authors:  Y T Kwon; L H Tsai; J E Crandall
Journal:  J Comp Neurol       Date:  1999-12-13       Impact factor: 3.215

Review 5.  Cyclin dependent kinase regulation.

Authors:  E Lees
Journal:  Curr Opin Cell Biol       Date:  1995-12       Impact factor: 8.382

Review 6.  CDK inhibition and cancer therapy.

Authors:  M D Garrett; A Fattaey
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

Review 7.  Cdk5 behind the wheel: a role in trafficking and transport?

Authors:  Deanna S Smith; Li Huei Tsai
Journal:  Trends Cell Biol       Date:  2002-01       Impact factor: 20.808

8.  Structure and regulation of the CDK5-p25(nck5a) complex.

Authors:  C Tarricone; R Dhavan; J Peng; L B Areces; L H Tsai; A Musacchio
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

9.  Clubbed thiazoles by MAOS: a novel approach to cyclin-dependent kinase 5/p25 inhibitors as a potential treatment for Alzheimer's disease.

Authors:  Mahendra Ramesh Shiradkar; Kalyan Chakravarthy Akula; Varaprasad Dasari; Vijayakumar Baru; Bhoomeshwar Chiningiri; Santosh Gandhi; Ranjit Kaur
Journal:  Bioorg Med Chem       Date:  2007-01-30       Impact factor: 3.641

Review 10.  Role of cdk5 in the pathogenesis of Alzheimer's disease.

Authors:  Lit-Fui Lau; Michael K Ahlijanian
Journal:  Neurosignals       Date:  2003 Sep-Oct
View more
  1 in total

1.  Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.

Authors:  Xiaolong Li; Xiaowei Wang; Zibin Tian; Houling Zhao; Da Liang; Weisong Li; Yujin Qiu; Shaoyong Lu
Journal:  J Mol Model       Date:  2014-08-21       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.